High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems

Europace

Volumn 10, Issue 3, 2008, Pages 347-350

  Day, John D ^a,f   Olshansky, Brian ^b   Moore, Stephen ^c   Brown, Scott ^d   Stolen, Kira Q ^e   Lerew, Darin R ^e  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c North Ohio Research Ltd   (United States)

^d Integra Group   (United States)

^e Boston Scientific CRM   (United States)

^f INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Defibrillation energy requirements; Implantable cardioverter defibrillator; Ventricular fibrillation

Indexed keywords

LEAD;

ARTICLE; CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; ENERGY; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SAFETY;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT SAFETY; HEART FAILURE; HUMANS; PROSPECTIVE STUDIES;

EID: 44649093349     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun027     Document Type: Article

References (21)

1. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation 1985;71:289- 96.
2. Neuzner J, Liebrich A, Jung J, Himmrich E, Pitschner HF, Winter J et al. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial. Am J Cardiol 1999;83:34D-39D.
3. Strickberger SA, Daoud EG, Davidson T, Weiss R, Bogun F, Knight BP et al. Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation 1997;96:1217-23.
4. Sylvester E, Johnson E, Hess P, Malkin R. Defibrillation causes immediate cardiac dilation in humans. J Cardiovasc Electrophysiol 2003;14:832-6.
5. Rollan MJ, San Roman JA, Bratos JL, Munoz AC, Casero A, Carrasco FJ. Acute pulmonary edema secondary to myocardial damage after electrical cardioversion. Pacing Clin Electrophysiol 2003;26:2330-2.
6. Hasdemir C, Shah N, Rao AP, Acosta H, Matsudaira K, Neas BR et al. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol 2002;13:144-50.
7. Frame R, Brodman R, Furman S, Kim SG, Roth J, Ferrick K et al. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol 1992;15:870-7.
8. Singer I, Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992;15:932- 49.
9. Vlay SC. Defibrillation threshold testing: necessary but evil? Am Heart J 1989;117:499-504.
10. Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah Ott P, Glatter KA et al. Inductionless or limited shock testing is possible in most patients with implantable cardioverter-defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study. Circulation 2007;115:2382-9.
11. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005;2:456-61.
12. Olshansky B, Day J, McGuire M, Pratt T. Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs (INTRINSIC RV): design and clinical protocol. Pacing Clin Electrophysiol 2005;28:62-6.
13. Olshansky B, Day JD, Moore S, Gering L, Rosenbaum M, McGuire M et al. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation 2007;115:9-16.
14. Ideker RE, Epstein AE, Plumb VJ. Should shocks still be administered during implantable cardioverter-defibrillator insertion? Heart Rhythm 2005;2:462-3.
15. Strickberger SA, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 2004;44:88-91.
16. Swerdlow CD. Reappraisal of implant testing of implantable cardioverter defibrillators. J Am Coll Cardiol 2004;44:92-4.
17. Green UB, Garg A, Al Kandari F, Ungab G, Tone L, Feld GK. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing. J Interv Card Electrophysiol 2003;8:71-5.
18. Glikson M, Gurevitz OT, Trusty JM, Sharma V, Luria DM, Eldar M et al. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions. Am J Cardiol 2004;94:1445-9.
19. Ellenbogen KA, Wood MA, Gilligan DM, Crofts T, London W, McClish D. Immediate reproducibility of upper limit of vulnerability measurements in patients undergoing transvenous implantable cardioverter defibrillator implantation. J Cardiovasc Electrophysiol 1998;9:588-95.
20. Higgins S, Mann D, Calkins H, Estes NA, Strickberger SA, Breiter D et al. One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: an analysis from the Low Energy Safety Study (LESS). Heart Rhythm 2005;2:117-22.
21. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation 2002;105:2043-8.